Details of the Active Pharmaceutical Ingredient (API)
General Information of API (ID: D00267) | |||||
---|---|---|---|---|---|
Name |
Felodipine
|
||||
Synonyms |
Click to Show/Hide the Synonyms of This API
felodipine; 72509-76-3; Plendil; Flodil; Renedil; Feloday; Munobal; Splendil; dl-Felodipine; Perfudal; Prevex; Felodipina; Felodipinum; Felodipinum [INN-Latin]; Felodipina [INN-Spanish]; C18H19Cl2NO4; 86189-69-7; Felodipine (Plendil); H 154/82; Plendil ER; Felogard; MFCD00868316; Penedil; Preslow; Munobal Retard; Plendil Retard; H-154/82; Plendil Depottab; MLS000069629; CHEBI:585948; Felodur ER; AGON SR; NCGC00015455-03; Plandil; SMR000058204; DSSTox_CID_3042; DSSTox_RID_76848; DSSTox_GSID_23042; Felodipine [USAN:BAN:INN]; Logimax; Plendil (TN); CGH-869; SR-01000075890; BRN 4331472; Perfuda; Plendil;Renedil; Felodipine, solid; C08CA02; Felodipine,(S); Felodipine [USAN:USP:INN:BAN]; 3,5-dicarboxylate; Prestwick_797; CAS-72509-76-3; Felodipine (dl form); PubChem15919; Opera_ID_1873; Prestwick0_000478; Prestwick1_000478; Prestwick2_000478; Prestwick3_000478; (.+/-.)-Felodipine; F 9677; CHEMBL1480; Lopac0_000508; SCHEMBL26398; BSPBio_000616; AE-641/11429675; MLS001077361; MLS001333735; MLS002153409; MLS002153832; MLS003876820; BIDD:GT0733; SPBio_002555; BPBio1_000678; Felodipine (JP17/USP/INN); GTPL4190; CHEMBL3196476; DTXSID4023042; SCHEMBL13460298; BDBM189379; HMS1569O18; HMS2089J05; HMS2096O18; HMS2232D24; HMS3259F12; HMS3261F17; HMS3651O21; HMS3713O18; HMS3884I14; Pharmakon1600-01505887; BCP02192; BCP22685; HY-B0309; 2,6-dimethyl-1,4-dihydropyridine-; Tox21_110155; Tox21_500508; ANW-42236; CA-236; NSC760343; AKOS015891545; Tox21_110155_1; AC-2124; BCP9000680; CCG-204599; DB01023; KS-1264; LP00508; MCULE-8253440089; NC00721; NSC-760343; SDCCGSBI-0050492.P002; NCGC00015455-04; NCGC00015455-05; NCGC00015455-06; NCGC00015455-07; NCGC00015455-08; NCGC00015455-10; NCGC00015455-24; NCGC00024087-02; NCGC00093906-01; NCGC00093906-02; NCGC00261193-01; AC-24403; AK543880; SMR002529504; SY053174; AB0014113; 3-ethyl 5-methyl 4-(2,3-dichlorophenyl)-; EU-0100508; FT-0626393; FT-0660933; FT-0668475; SW219299-1; EN300-70726; D00319; S-8162; 509F763; Q420644; SR-01000075890-1; SR-01000075890-4; BRD-A30815329-001-03-0; Z239864852; Felodipine, European Pharmacopoeia (EP) Reference Standard; Felodipine, United States Pharmacopeia (USP) Reference Standard
|
||||
Clinical Status |
Approved
|
||||
Disease Indication | Essential hypertension | ICD-11: BA00 | [1] | ||
PubChem CID | |||||
Formula |
C18H19Cl2NO4
|
||||
Canonical SMILES |
CCOC(=O)C1=C(NC(=C(C1C2=C(C(=CC=C2)Cl)Cl)C(=O)OC)C)C
|
||||
InChI |
1S/C18H19Cl2NO4/c1-5-25-18(23)14-10(3)21-9(2)13(17(22)24-4)15(14)11-7-6-8-12(19)16(11)20/h6-8,15,21H,5H2,1-4H3
|
||||
InChIKey |
RZTAMFZIAATZDJ-UHFFFAOYSA-N
|
||||
Click to Show/Hide the Molecular Data (Structure/Property) of This API | |||||
Structure |
<iframe style="width: 300px; height: 300px;" frameborder="0" src="https://embed.molview.org/v1/?mode=balls&cid=3333"></iframe>
|
||||
3D MOL | 2D MOL | ||||
Physicochemical Properties | Molecular Weight | 384.2 | Topological Polar Surface Area | 64.599 | |
XlogP | 3.9 | Complexity | 614 | ||
Heavy Atom Count | 25 | Rotatable Bond Count | 6 | ||
Hydrogen Bond Donor Count | 1 | Hydrogen Bond Acceptor Count | 5 | ||
Full List of Drug Formulations (DFMs) Containing This API | ||||||
---|---|---|---|---|---|---|
Felodipine 10 mg tablet | Click to Show/Hide the Full List of Formulation(s): 17 Formulation(s) | |||||
Drug Formulation 1 | DFM Info click to show the detail info of this DFM | |||||
All DIGs | Click to Show/Hide the Full List of DIGs in This DFM
Anhydrous lactose; Fd&c red no. 40; Sodium stearyl fumarate; Fd&c blue no. 2; Propyl gallate; Titanium dioxide; Sodium aluminium silicate; Polyethylene glycol 400; Polyoxyl 40 hydrogenated castor oil; Silicon dioxide; Cellulose, microcrystalline; Hydroxypropyl cellulose (type h); Hypromellose 2910 (15000 mpa.s); Hypromelloses
|
|||||
Dosage Form | 24 HR Extended Release Oral Tablet | |||||
Company | Jubilant Cadista Pharmaceuticals | |||||
DIG(s) with Biological Activity | ||||||
DIG Name | DIG Info | Representative Biological Activity of This DIG | REF | |||
Allura red AC dye | DIG Info | Solute carrier SLCO2B1 (Ki = 4.7 uM) | [2] | |||
FD&C blue no. 2 | DIG Info | Adenosine receptor A3 (IC50 = 1 uM) | [2] | |||
Allura red AC dye | DIG Info | Solute carrier SLCO2B1 (Ki = 2.59 uM) | [3] | |||
Propyl gallate | DIG Info | Arachidonate 5-lipoxygenase (Ki = 0.43 uM) | [2] | |||
Sodium stearyl fumarate | DIG Info | Leukemia K562 cells (IC50 = 20.2 ug.mL-1) | [4] | |||
Hydrogenated polyoxyl 40 castor oil | DIG Info | Cytochrome P450 2C9 (IC50 = 30 uM) | [5] | |||
Polyethylene glycol 400 | DIG Info | Albendazole monooxygenase (IC50 = 10.77 mg.mL-1) | [6] | |||
Silicon dioxide | DIG Info | Albendazole monooxygenase (Protein expression downregulation) | [7] | |||
Drug Formulation 2 | DFM Info click to show the detail info of this DFM | |||||
All DIGs | Click to Show/Hide the Full List of DIGs in This DFM
Butylated hydroxytoluene; Sodium stearyl fumarate; Fd&c blue no. 2; Fd&c yellow no. 6; Butylated hydroxyanisole; Titanium dioxide; Silicon dioxide; Cellulose, microcrystalline; Hypromelloses; Polydextrose; Polyethylene glycols; Povidones
|
|||||
Dosage Form | 24 HR Extended Release Oral Tablet | |||||
Company | Mylan Pharamceuticals; NCS HealthCare of KY, Inc dba Vangard Labs | |||||
DIG(s) with Biological Activity | ||||||
DIG Name | DIG Info | Representative Biological Activity of This DIG | REF | |||
Butylated hydroxytoluene | DIG Info | Carbonic anhydrase II (Ki = 630 nM) | [8] | |||
Sunset yellow FCF | DIG Info | Solute carrier SLCO2B1 (Ki = 68.4 uM) | [3] | |||
FD&C blue no. 2 | DIG Info | Adenosine receptor A3 (IC50 = 1 uM) | [2] | |||
Sodium stearyl fumarate | DIG Info | Leukemia K562 cells (IC50 = 20.2 ug.mL-1) | [4] | |||
Butylhydroxyanisole | DIG Info | Prostaglandin G/H synthase 2 (IC50 = 2.6 uM) | [2] | |||
Silicon dioxide | DIG Info | Albendazole monooxygenase (Protein expression downregulation) | [7] | |||
Drug Formulation 3 | DFM Info click to show the detail info of this DFM | |||||
All DIGs | Click to Show/Hide the Full List of DIGs in This DFM
D&c yellow no. 10; Fd&c red no. 40; Fd&c blue no. 2; Titanium dioxide; Hypromellose; Povidone; Silicon dioxide; Aluminum oxide; Carnauba wax; Cellulose, microcrystalline; Hydroxypropyl cellulose; Polyethylene glycol; Starch, corn
|
|||||
Dosage Form | 24 HR Extended Release Oral Tablet | |||||
Company | Physicians Total Care | |||||
DIG(s) with Biological Activity | ||||||
DIG Name | DIG Info | Representative Biological Activity of This DIG | REF | |||
Allura red AC dye | DIG Info | Solute carrier SLCO2B1 (Ki = 4.7 uM) | [2] | |||
FD&C blue no. 2 | DIG Info | Adenosine receptor A3 (IC50 = 1 uM) | [2] | |||
Quinoline yellow WS | DIG Info | Estrogen receptor alpha (IC50 = 18 uM) | [2] | |||
Allura red AC dye | DIG Info | Solute carrier SLCO2B1 (Ki = 2.59 uM) | [3] | |||
Hypromellose | DIG Info | Cytochrome P450 3A5 (IC50 = 19.4 uM) | [9] | |||
Povidone | DIG Info | Cholesterol 25-hydroxylase (IC50 = 78.3 uM) | [9] | |||
Silicon dioxide | DIG Info | Albendazole monooxygenase (Protein expression downregulation) | [7] | |||
Drug Formulation 4 | DFM Info click to show the detail info of this DFM | |||||
All DIGs | Click to Show/Hide the Full List of DIGs in This DFM
Lactose; Sodium stearyl fumarate; Propyl gallate; Ferric oxide red; Ferric oxide yellow; Magnesium oxide; Propylene glycol; Talc; Titanium dioxide; Polyoxyl 40 hydrogenated castor oil; Silicon dioxide; Cellulose, microcrystalline; Hydroxypropyl cellulose (type h); Hypromelloses
|
|||||
Dosage Form | 24 HR Extended Release Oral Tablet | |||||
Company | A-S Medication Solutions | |||||
DIG(s) with Biological Activity | ||||||
DIG Name | DIG Info | Representative Biological Activity of This DIG | REF | |||
Propyl gallate | DIG Info | Arachidonate 5-lipoxygenase (Ki = 0.43 uM) | [2] | |||
Sodium stearyl fumarate | DIG Info | Leukemia K562 cells (IC50 = 20.2 ug.mL-1) | [4] | |||
Propylene glycol | DIG Info | Albendazole monooxygenase (Inhibition ratio < 20 %) | [6] | |||
Hydrogenated polyoxyl 40 castor oil | DIG Info | Cytochrome P450 2C9 (IC50 = 30 uM) | [5] | |||
Silicon dioxide | DIG Info | Albendazole monooxygenase (Protein expression downregulation) | [7] | |||
Drug Formulation 5 | DFM Info click to show the detail info of this DFM | |||||
All DIGs | Click to Show/Hide the Full List of DIGs in This DFM
Lactose monohydrate; Sodium stearyl fumarate; Propyl gallate; Ferric oxide red; Ferric oxide yellow; Titanium dioxide; Aluminum silicate; Polyethylene glycol 6000; Polyoxyl 40 hydrogenated castor oil; Silicon dioxide; Cellulose, microcrystalline; Hydroxypropyl cellulose; Hypromellose 2208 (100 mpa.s); Hypromellose 2910 (50 mpa.s); Hypromellose 2910 (6 mpa.s)
|
|||||
Dosage Form | 24 HR Extended Release Oral Tablet | |||||
Company | Aurobindo Pharma; Citron Pharma | |||||
DIG(s) with Biological Activity | ||||||
DIG Name | DIG Info | Representative Biological Activity of This DIG | REF | |||
Propyl gallate | DIG Info | Arachidonate 5-lipoxygenase (Ki = 0.43 uM) | [2] | |||
Sodium stearyl fumarate | DIG Info | Leukemia K562 cells (IC50 = 20.2 ug.mL-1) | [4] | |||
Hydrogenated polyoxyl 40 castor oil | DIG Info | Cytochrome P450 2C9 (IC50 = 30 uM) | [5] | |||
Polyethylene glycol 6000 | DIG Info | Albendazole monooxygenase (Inhibition ratio < 70 %) | [6] | |||
Silicon dioxide | DIG Info | Albendazole monooxygenase (Protein expression downregulation) | [7] | |||
Drug Formulation 6 | DFM Info click to show the detail info of this DFM | |||||
All DIGs | Click to Show/Hide the Full List of DIGs in This DFM
Lactose monohydrate; D&c yellow no. 10; Sodium stearyl fumarate; Fd&c yellow no. 6; Titanium dioxide; Polyoxyl 40 hydrogenated castor oil; Silicon dioxide; Cellulose, microcrystalline; Hydroxypropyl cellulose; Hypromelloses; Polyethylene glycol
|
|||||
Dosage Form | 24 HR Extended Release Oral Tablet | |||||
Company | Wockhardt | |||||
DIG(s) with Biological Activity | ||||||
DIG Name | DIG Info | Representative Biological Activity of This DIG | REF | |||
Sunset yellow FCF | DIG Info | Solute carrier SLCO2B1 (Ki = 68.4 uM) | [3] | |||
Quinoline yellow WS | DIG Info | Estrogen receptor alpha (IC50 = 18 uM) | [2] | |||
Sodium stearyl fumarate | DIG Info | Leukemia K562 cells (IC50 = 20.2 ug.mL-1) | [4] | |||
Hydrogenated polyoxyl 40 castor oil | DIG Info | Cytochrome P450 2C9 (IC50 = 30 uM) | [5] | |||
Silicon dioxide | DIG Info | Albendazole monooxygenase (Protein expression downregulation) | [7] | |||
Drug Formulation 7 | DFM Info click to show the detail info of this DFM | |||||
All DIGs | Click to Show/Hide the Full List of DIGs in This DFM
D&c yellow no. 10; Fd&c red no. 40; Fd&c blue no. 2; Titanium dioxide; Povidone; Silicon dioxide; Aluminum oxide; Carnauba wax; Cellulose, microcrystalline; Hydroxypropyl cellulose; Hypromelloses; Polyethylene glycol; Starch, corn
|
|||||
Dosage Form | 24 HR Extended Release Tablet | |||||
Company | PD-Rx Pharmaceuticals | |||||
DIG(s) with Biological Activity | ||||||
DIG Name | DIG Info | Representative Biological Activity of This DIG | REF | |||
Allura red AC dye | DIG Info | Solute carrier SLCO2B1 (Ki = 4.7 uM) | [2] | |||
FD&C blue no. 2 | DIG Info | Adenosine receptor A3 (IC50 = 1 uM) | [2] | |||
Quinoline yellow WS | DIG Info | Estrogen receptor alpha (IC50 = 18 uM) | [2] | |||
Allura red AC dye | DIG Info | Solute carrier SLCO2B1 (Ki = 2.59 uM) | [3] | |||
Povidone | DIG Info | Cholesterol 25-hydroxylase (IC50 = 78.3 uM) | [9] | |||
Silicon dioxide | DIG Info | Albendazole monooxygenase (Protein expression downregulation) | [7] | |||
Drug Formulation 8 | DFM Info click to show the detail info of this DFM | |||||
All DIGs | Click to Show/Hide the Full List of DIGs in This DFM
Lactose; Sodium stearyl fumarate; Propyl gallate; Ferric oxide red; Ferric oxide yellow; Magnesium oxide; Propylene glycol; Talc; Titanium dioxide; Polyoxyl 40 hydrogenated castor oil; Cellulose, microcrystalline; Colloidal silicon dioxide; Hydroxypropyl cellulose; Hypromelloses
|
|||||
Dosage Form | 24 HR Extended Release Oral Tablet | |||||
Company | Torrent Pharmaceuticals | |||||
DIG(s) with Biological Activity | ||||||
DIG Name | DIG Info | Representative Biological Activity of This DIG | REF | |||
Propyl gallate | DIG Info | Arachidonate 5-lipoxygenase (Ki = 0.43 uM) | [2] | |||
Sodium stearyl fumarate | DIG Info | Leukemia K562 cells (IC50 = 20.2 ug.mL-1) | [4] | |||
Propylene glycol | DIG Info | Albendazole monooxygenase (Inhibition ratio < 20 %) | [6] | |||
Hydrogenated polyoxyl 40 castor oil | DIG Info | Cytochrome P450 2C9 (IC50 = 30 uM) | [5] | |||
Drug Formulation 9 | DFM Info click to show the detail info of this DFM | |||||
All DIGs | Click to Show/Hide the Full List of DIGs in This DFM
D&c yellow no. 10; Fd&c red no. 40; Fd&c blue no. 2; Titanium dioxide; Silicon dioxide; Aluminum oxide; Carnauba wax; Hydroxypropyl cellulose (1200000 mw); Hypromellose, unspecified; Microcrystalline cellulose; Polyethylene glycol, unspecified; Povidone, unspecified
|
|||||
Dosage Form | 24 HR Extended Release Oral Tablet | |||||
Company | A-S Medication Solutions | |||||
DIG(s) with Biological Activity | ||||||
DIG Name | DIG Info | Representative Biological Activity of This DIG | REF | |||
Allura red AC dye | DIG Info | Solute carrier SLCO2B1 (Ki = 4.7 uM) | [2] | |||
FD&C blue no. 2 | DIG Info | Adenosine receptor A3 (IC50 = 1 uM) | [2] | |||
Quinoline yellow WS | DIG Info | Estrogen receptor alpha (IC50 = 18 uM) | [2] | |||
Allura red AC dye | DIG Info | Solute carrier SLCO2B1 (Ki = 2.59 uM) | [3] | |||
Silicon dioxide | DIG Info | Albendazole monooxygenase (Protein expression downregulation) | [7] | |||
Drug Formulation 10 | DFM Info click to show the detail info of this DFM | |||||
All DIGs | Click to Show/Hide the Full List of DIGs in This DFM
D&c yellow no. 10; Fd&c red no. 40; Fd&c blue no. 2; Titanium dioxide; Silicon dioxide; Aluminum oxide; Carnauba wax; Cellulose, microcrystalline; Hydroxypropyl cellulose (type h); Hypromelloses; Polyethylene glycols; Povidones
|
|||||
Dosage Form | 24 HR Extended Release Oral Tablet | |||||
Company | AvKARE; Sun Pharmaceutical Industries | |||||
DIG(s) with Biological Activity | ||||||
DIG Name | DIG Info | Representative Biological Activity of This DIG | REF | |||
Allura red AC dye | DIG Info | Solute carrier SLCO2B1 (Ki = 4.7 uM) | [2] | |||
FD&C blue no. 2 | DIG Info | Adenosine receptor A3 (IC50 = 1 uM) | [2] | |||
Quinoline yellow WS | DIG Info | Estrogen receptor alpha (IC50 = 18 uM) | [2] | |||
Allura red AC dye | DIG Info | Solute carrier SLCO2B1 (Ki = 2.59 uM) | [3] | |||
Silicon dioxide | DIG Info | Albendazole monooxygenase (Protein expression downregulation) | [7] | |||
Drug Formulation 11 | DFM Info click to show the detail info of this DFM | |||||
All DIGs | Click to Show/Hide the Full List of DIGs in This DFM
D&c yellow no. 10; Fd&c red no. 40; Fd&c blue no. 2; Titanium dioxide; Silicon dioxide; Aluminum oxide; Carnauba wax; Cellulose, microcrystalline; Hydroxypropyl cellulose; Hypromelloses; Polyethylene glycols; Povidone k29/32
|
|||||
Dosage Form | 24 HR Extended Release Oral Tablet | |||||
Company | Richmond Pharmaceuticals | |||||
DIG(s) with Biological Activity | ||||||
DIG Name | DIG Info | Representative Biological Activity of This DIG | REF | |||
Allura red AC dye | DIG Info | Solute carrier SLCO2B1 (Ki = 4.7 uM) | [2] | |||
FD&C blue no. 2 | DIG Info | Adenosine receptor A3 (IC50 = 1 uM) | [2] | |||
Quinoline yellow WS | DIG Info | Estrogen receptor alpha (IC50 = 18 uM) | [2] | |||
Allura red AC dye | DIG Info | Solute carrier SLCO2B1 (Ki = 2.59 uM) | [3] | |||
Silicon dioxide | DIG Info | Albendazole monooxygenase (Protein expression downregulation) | [7] | |||
Drug Formulation 12 | DFM Info click to show the detail info of this DFM | |||||
All DIGs | Click to Show/Hide the Full List of DIGs in This DFM
Anhydrous lactose; Sodium stearyl fumarate; Propyl gallate; Ferric oxide red; Ferric oxide yellow; Titanium dioxide; Aluminum silicate; Povidone; Alcohol; Cellulose, microcrystalline; Hypromelloses; Polyethylene glycols
|
|||||
Dosage Form | 24 HR Extended Release Oral Tablet | |||||
Company | AstraZeneca | |||||
DIG(s) with Biological Activity | ||||||
DIG Name | DIG Info | Representative Biological Activity of This DIG | REF | |||
Propyl gallate | DIG Info | Arachidonate 5-lipoxygenase (Ki = 0.43 uM) | [2] | |||
Sodium stearyl fumarate | DIG Info | Leukemia K562 cells (IC50 = 20.2 ug.mL-1) | [4] | |||
Povidone | DIG Info | Cholesterol 25-hydroxylase (IC50 = 78.3 uM) | [9] | |||
Drug Formulation 13 | DFM Info click to show the detail info of this DFM | |||||
All DIGs | Click to Show/Hide the Full List of DIGs in This DFM
Lactose monohydrate; Sodium stearyl fumarate; Magnesium aluminum silicate; Titanium dioxide; Polyethylene glycol 400; Polyoxyl 40 hydrogenated castor oil; Hydroxypropyl cellulose; Hypromellose 2208 (15000 mpa.s); Hypromellose 2910 (5 mpa.s)
|
|||||
Dosage Form | 24 HR Extended Release Oral Tablet | |||||
Company | Heritage Pharmaceuticals | |||||
DIG(s) with Biological Activity | ||||||
DIG Name | DIG Info | Representative Biological Activity of This DIG | REF | |||
Sodium stearyl fumarate | DIG Info | Leukemia K562 cells (IC50 = 20.2 ug.mL-1) | [4] | |||
Hydrogenated polyoxyl 40 castor oil | DIG Info | Cytochrome P450 2C9 (IC50 = 30 uM) | [5] | |||
Polyethylene glycol 400 | DIG Info | Albendazole monooxygenase (IC50 = 10.77 mg.mL-1) | [6] | |||
Drug Formulation 14 | DFM Info click to show the detail info of this DFM | |||||
All DIGs | Click to Show/Hide the Full List of DIGs in This DFM
Lactose; Sodium stearyl fumarate; Propyl gallate; Calcium silicate; Ferric oxide red; Titanium dioxide; Triacetin; Cellulose, microcrystalline; Hydroxypropyl cellulose (type h); Hypromelloses; Peg-40 castor oil
|
|||||
Dosage Form | 24 HR Extended Release Oral Tablet | |||||
Company | Qualitest Pharmaceuticals | |||||
DIG(s) with Biological Activity | ||||||
DIG Name | DIG Info | Representative Biological Activity of This DIG | REF | |||
Propyl gallate | DIG Info | Arachidonate 5-lipoxygenase (Ki = 0.43 uM) | [2] | |||
Sodium stearyl fumarate | DIG Info | Leukemia K562 cells (IC50 = 20.2 ug.mL-1) | [4] | |||
Drug Formulation 15 | DFM Info click to show the detail info of this DFM | |||||
All DIGs | Click to Show/Hide the Full List of DIGs in This DFM
Anhydrous lactose; Sodium stearyl fumarate; Propyl gallate; Ferric oxide red; Ferric oxide yellow; Titanium dioxide; Aluminum silicate; Alcohol; Cellulose, microcrystalline; Hypromelloses; Polyethylene glycols; Povidones
|
|||||
Dosage Form | 24 HR Extended Release Oral Tablet | |||||
Company | Bryant Ranch Prepack | |||||
DIG(s) with Biological Activity | ||||||
DIG Name | DIG Info | Representative Biological Activity of This DIG | REF | |||
Propyl gallate | DIG Info | Arachidonate 5-lipoxygenase (Ki = 0.43 uM) | [2] | |||
Sodium stearyl fumarate | DIG Info | Leukemia K562 cells (IC50 = 20.2 ug.mL-1) | [4] | |||
Drug Formulation 16 | DFM Info click to show the detail info of this DFM | |||||
All DIGs | Click to Show/Hide the Full List of DIGs in This DFM
Lactose monohydrate; Sodium stearyl fumarate; Ferric oxide red; Ferric oxide yellow; Kaolin; Titanium dioxide; Polyoxyl 40 hydrogenated castor oil; Cellulose, microcrystalline; Hydroxypropyl cellulose (type h); Hypromelloses; Polyethylene glycols
|
|||||
Dosage Form | 24 HR Extended Release Oral Tablet | |||||
Company | A-S Medication Solutions; Glenmark Pharmaceutials; Medsource Pharmaceuticals | |||||
DIG(s) with Biological Activity | ||||||
DIG Name | DIG Info | Representative Biological Activity of This DIG | REF | |||
Sodium stearyl fumarate | DIG Info | Leukemia K562 cells (IC50 = 20.2 ug.mL-1) | [4] | |||
Hydrogenated polyoxyl 40 castor oil | DIG Info | Cytochrome P450 2C9 (IC50 = 30 uM) | [5] | |||
Drug Formulation 17 | DFM Info click to show the detail info of this DFM | |||||
All DIGs | Click to Show/Hide the Full List of DIGs in This DFM
Lactose; Sodium stearyl fumarate; Titanium dioxide; Polyethylene glycol
|
|||||
Dosage Form | 24 HR Extended Release Oral Tablet | |||||
Company | Ranbaxy Pharmaceuticals | |||||
DIG(s) with Biological Activity | ||||||
DIG Name | DIG Info | Representative Biological Activity of This DIG | REF | |||
Sodium stearyl fumarate | DIG Info | Leukemia K562 cells (IC50 = 20.2 ug.mL-1) | [4] | |||
Felodipine 5 mg tablet | Click to Show/Hide the Full List of Formulation(s): 16 Formulation(s) | |||||
Drug Formulation 1 | DFM Info click to show the detail info of this DFM | |||||
All DIGs | Click to Show/Hide the Full List of DIGs in This DFM
Butylated hydroxytoluene; D&c yellow no. 10; Sodium stearyl fumarate; Fd&c blue no. 2; Fd&c yellow no. 6; Butylated hydroxyanisole; Titanium dioxide; Silicon dioxide; Cellulose, microcrystalline; Hypromelloses; Polydextrose; Polyethylene glycols; Povidones
|
|||||
Dosage Form | 24 HR Extended Release Oral Tablet | |||||
Company | Mylan Pharamceuticals; NCS HealthCare of KY, Inc dba Vangard Labs | |||||
DIG(s) with Biological Activity | ||||||
DIG Name | DIG Info | Representative Biological Activity of This DIG | REF | |||
Butylated hydroxytoluene | DIG Info | Carbonic anhydrase II (Ki = 630 nM) | [8] | |||
Sunset yellow FCF | DIG Info | Solute carrier SLCO2B1 (Ki = 68.4 uM) | [3] | |||
FD&C blue no. 2 | DIG Info | Adenosine receptor A3 (IC50 = 1 uM) | [2] | |||
Quinoline yellow WS | DIG Info | Estrogen receptor alpha (IC50 = 18 uM) | [2] | |||
Sodium stearyl fumarate | DIG Info | Leukemia K562 cells (IC50 = 20.2 ug.mL-1) | [4] | |||
Butylhydroxyanisole | DIG Info | Prostaglandin G/H synthase 2 (IC50 = 2.6 uM) | [2] | |||
Silicon dioxide | DIG Info | Albendazole monooxygenase (Protein expression downregulation) | [7] | |||
Drug Formulation 2 | DFM Info click to show the detail info of this DFM | |||||
All DIGs | Click to Show/Hide the Full List of DIGs in This DFM
D&c yellow no. 10; Fd&c red no. 40; Titanium dioxide; Hypromellose; Polysorbate 80; Povidone; Silicon dioxide; Aluminum oxide; Carnauba wax; Cellulose, microcrystalline; Hydroxypropyl cellulose; Polyethylene glycol; Starch, corn
|
|||||
Dosage Form | 24 HR Extended Release Oral Tablet | |||||
Company | Physicians Total Care | |||||
DIG(s) with Biological Activity | ||||||
DIG Name | DIG Info | Representative Biological Activity of This DIG | REF | |||
Allura red AC dye | DIG Info | Solute carrier SLCO2B1 (Ki = 4.7 uM) | [2] | |||
Quinoline yellow WS | DIG Info | Estrogen receptor alpha (IC50 = 18 uM) | [2] | |||
Allura red AC dye | DIG Info | Solute carrier SLCO2B1 (Ki = 2.59 uM) | [3] | |||
Hypromellose | DIG Info | Cytochrome P450 3A5 (IC50 = 19.4 uM) | [9] | |||
Polysorbate 80 | DIG Info | Prostaglandin G/H synthase 1 (IC50 = 1 uM) | [2] | |||
Povidone | DIG Info | Cholesterol 25-hydroxylase (IC50 = 78.3 uM) | [9] | |||
Silicon dioxide | DIG Info | Albendazole monooxygenase (Protein expression downregulation) | [7] | |||
Drug Formulation 3 | DFM Info click to show the detail info of this DFM | |||||
All DIGs | Click to Show/Hide the Full List of DIGs in This DFM
Lactose monohydrate; Sodium stearyl fumarate; Propyl gallate; Ferric oxide red; Ferric oxide yellow; Titanium dioxide; Aluminum silicate; Polyethylene glycol 6000; Polyoxyl 40 hydrogenated castor oil; Silicon dioxide; Cellulose, microcrystalline; Hydroxypropyl cellulose; Hypromellose 2208 (100 mpa.s); Hypromellose 2910 (50 mpa.s); Hypromellose 2910 (6 mpa.s)
|
|||||
Dosage Form | 24 HR Extended Release Oral Tablet | |||||
Company | Aurobindo Pharma; Citron Pharma | |||||
DIG(s) with Biological Activity | ||||||
DIG Name | DIG Info | Representative Biological Activity of This DIG | REF | |||
Propyl gallate | DIG Info | Arachidonate 5-lipoxygenase (Ki = 0.43 uM) | [2] | |||
Sodium stearyl fumarate | DIG Info | Leukemia K562 cells (IC50 = 20.2 ug.mL-1) | [4] | |||
Hydrogenated polyoxyl 40 castor oil | DIG Info | Cytochrome P450 2C9 (IC50 = 30 uM) | [5] | |||
Polyethylene glycol 6000 | DIG Info | Albendazole monooxygenase (Inhibition ratio < 70 %) | [6] | |||
Silicon dioxide | DIG Info | Albendazole monooxygenase (Protein expression downregulation) | [7] | |||
Drug Formulation 4 | DFM Info click to show the detail info of this DFM | |||||
All DIGs | Click to Show/Hide the Full List of DIGs in This DFM
Anhydrous lactose; Sodium stearyl fumarate; Propyl gallate; Ferric oxide yellow; Titanium dioxide; Sodium aluminium silicate; Polyethylene glycol 400; Polyoxyl 40 hydrogenated castor oil; Silicon dioxide; Cellulose, microcrystalline; Hydroxypropyl cellulose (type h); Hypromellose 2910 (15000 mpa.s); Hypromelloses
|
|||||
Dosage Form | 24 HR Extended Release Oral Tablet | |||||
Company | Jubilant Cadista Pharmaceuticals | |||||
DIG(s) with Biological Activity | ||||||
DIG Name | DIG Info | Representative Biological Activity of This DIG | REF | |||
Propyl gallate | DIG Info | Arachidonate 5-lipoxygenase (Ki = 0.43 uM) | [2] | |||
Sodium stearyl fumarate | DIG Info | Leukemia K562 cells (IC50 = 20.2 ug.mL-1) | [4] | |||
Hydrogenated polyoxyl 40 castor oil | DIG Info | Cytochrome P450 2C9 (IC50 = 30 uM) | [5] | |||
Polyethylene glycol 400 | DIG Info | Albendazole monooxygenase (IC50 = 10.77 mg.mL-1) | [6] | |||
Silicon dioxide | DIG Info | Albendazole monooxygenase (Protein expression downregulation) | [7] | |||
Drug Formulation 5 | DFM Info click to show the detail info of this DFM | |||||
All DIGs | Click to Show/Hide the Full List of DIGs in This DFM
Lactose monohydrate; D&c yellow no. 10; Sodium stearyl fumarate; Fd&c yellow no. 6; Titanium dioxide; Polyoxyl 40 hydrogenated castor oil; Silicon dioxide; Cellulose, microcrystalline; Hydroxypropyl cellulose; Hypromelloses; Polyethylene glycol
|
|||||
Dosage Form | 24 HR Extended Release Oral Tablet | |||||
Company | Wockhardt | |||||
DIG(s) with Biological Activity | ||||||
DIG Name | DIG Info | Representative Biological Activity of This DIG | REF | |||
Sunset yellow FCF | DIG Info | Solute carrier SLCO2B1 (Ki = 68.4 uM) | [3] | |||
Quinoline yellow WS | DIG Info | Estrogen receptor alpha (IC50 = 18 uM) | [2] | |||
Sodium stearyl fumarate | DIG Info | Leukemia K562 cells (IC50 = 20.2 ug.mL-1) | [4] | |||
Hydrogenated polyoxyl 40 castor oil | DIG Info | Cytochrome P450 2C9 (IC50 = 30 uM) | [5] | |||
Silicon dioxide | DIG Info | Albendazole monooxygenase (Protein expression downregulation) | [7] | |||
Drug Formulation 6 | DFM Info click to show the detail info of this DFM | |||||
All DIGs | Click to Show/Hide the Full List of DIGs in This DFM
D&c yellow no. 10; Fd&c red no. 40; Titanium dioxide; Polysorbate 80; Povidone; Silicon dioxide; Aluminum oxide; Carnauba wax; Cellulose, microcrystalline; Hydroxypropyl cellulose; Hypromelloses; Polyethylene glycol; Starch, corn
|
|||||
Dosage Form | 24 HR Extended Release Oral Tablet | |||||
Company | RemedyRepack | |||||
DIG(s) with Biological Activity | ||||||
DIG Name | DIG Info | Representative Biological Activity of This DIG | REF | |||
Allura red AC dye | DIG Info | Solute carrier SLCO2B1 (Ki = 4.7 uM) | [2] | |||
Quinoline yellow WS | DIG Info | Estrogen receptor alpha (IC50 = 18 uM) | [2] | |||
Allura red AC dye | DIG Info | Solute carrier SLCO2B1 (Ki = 2.59 uM) | [3] | |||
Polysorbate 80 | DIG Info | Prostaglandin G/H synthase 1 (IC50 = 1 uM) | [2] | |||
Povidone | DIG Info | Cholesterol 25-hydroxylase (IC50 = 78.3 uM) | [9] | |||
Silicon dioxide | DIG Info | Albendazole monooxygenase (Protein expression downregulation) | [7] | |||
Drug Formulation 7 | DFM Info click to show the detail info of this DFM | |||||
All DIGs | Click to Show/Hide the Full List of DIGs in This DFM
Lactose; Sodium stearyl fumarate; Propyl gallate; Ferric oxide red; Ferric oxide yellow; Magnesium oxide; Propylene glycol; Talc; Titanium dioxide; Polyoxyl 40 hydrogenated castor oil; Cellulose, microcrystalline; Colloidal silicon dioxide; Hydroxypropyl cellulose; Hypromelloses
|
|||||
Dosage Form | 24 HR Extended Release Oral Tablet | |||||
Company | Medsource Pharmaceuticals; Torrent Pharmaceuticals | |||||
DIG(s) with Biological Activity | ||||||
DIG Name | DIG Info | Representative Biological Activity of This DIG | REF | |||
Propyl gallate | DIG Info | Arachidonate 5-lipoxygenase (Ki = 0.43 uM) | [2] | |||
Sodium stearyl fumarate | DIG Info | Leukemia K562 cells (IC50 = 20.2 ug.mL-1) | [4] | |||
Propylene glycol | DIG Info | Albendazole monooxygenase (Inhibition ratio < 20 %) | [6] | |||
Hydrogenated polyoxyl 40 castor oil | DIG Info | Cytochrome P450 2C9 (IC50 = 30 uM) | [5] | |||
Drug Formulation 8 | DFM Info click to show the detail info of this DFM | |||||
All DIGs | Click to Show/Hide the Full List of DIGs in This DFM
D&c yellow no. 10; Fd&c red no. 40; Titanium dioxide; Polysorbate 80; Silicon dioxide; Aluminum oxide; Carnauba wax; Cellulose, microcrystalline; Hydroxypropyl cellulose (type h); Hypromelloses; Polyethylene glycols; Povidones
|
|||||
Dosage Form | 24 HR Extended Release Oral Tablet | |||||
Company | AvKARE; PD-Rx Pharmaceuticals; Sun Pharmaceutical Industries | |||||
DIG(s) with Biological Activity | ||||||
DIG Name | DIG Info | Representative Biological Activity of This DIG | REF | |||
Allura red AC dye | DIG Info | Solute carrier SLCO2B1 (Ki = 4.7 uM) | [2] | |||
Quinoline yellow WS | DIG Info | Estrogen receptor alpha (IC50 = 18 uM) | [2] | |||
Allura red AC dye | DIG Info | Solute carrier SLCO2B1 (Ki = 2.59 uM) | [3] | |||
Polysorbate 80 | DIG Info | Prostaglandin G/H synthase 1 (IC50 = 1 uM) | [2] | |||
Silicon dioxide | DIG Info | Albendazole monooxygenase (Protein expression downregulation) | [7] | |||
Drug Formulation 9 | DFM Info click to show the detail info of this DFM | |||||
All DIGs | Click to Show/Hide the Full List of DIGs in This DFM
D&c yellow no. 10; Fd&c red no. 40; Titanium dioxide; Polysorbate 80; Silicon dioxide; Aluminum oxide; Carnauba wax; Cellulose, microcrystalline; Hydroxypropyl cellulose; Hypromelloses; Polyethylene glycols; Povidones
|
|||||
Dosage Form | 24 HR Extended Release Oral Tablet | |||||
Company | Bryant Ranch Prepack | |||||
DIG(s) with Biological Activity | ||||||
DIG Name | DIG Info | Representative Biological Activity of This DIG | REF | |||
Allura red AC dye | DIG Info | Solute carrier SLCO2B1 (Ki = 4.7 uM) | [2] | |||
Quinoline yellow WS | DIG Info | Estrogen receptor alpha (IC50 = 18 uM) | [2] | |||
Allura red AC dye | DIG Info | Solute carrier SLCO2B1 (Ki = 2.59 uM) | [3] | |||
Polysorbate 80 | DIG Info | Prostaglandin G/H synthase 1 (IC50 = 1 uM) | [2] | |||
Silicon dioxide | DIG Info | Albendazole monooxygenase (Protein expression downregulation) | [7] | |||
Drug Formulation 10 | DFM Info click to show the detail info of this DFM | |||||
All DIGs | Click to Show/Hide the Full List of DIGs in This DFM
D&c yellow no. 10; Fd&c red no. 40; Titanium dioxide; Polysorbate 80; Silicon dioxide; Aluminum oxide; Carnauba wax; Cellulose, microcrystalline; Hypromelloses; Polyethylene glycols; Povidone k29/32
|
|||||
Dosage Form | 24 HR Extended Release Oral Tablet | |||||
Company | Richmond Pharmaceuticals | |||||
DIG(s) with Biological Activity | ||||||
DIG Name | DIG Info | Representative Biological Activity of This DIG | REF | |||
Allura red AC dye | DIG Info | Solute carrier SLCO2B1 (Ki = 4.7 uM) | [2] | |||
Quinoline yellow WS | DIG Info | Estrogen receptor alpha (IC50 = 18 uM) | [2] | |||
Allura red AC dye | DIG Info | Solute carrier SLCO2B1 (Ki = 2.59 uM) | [3] | |||
Polysorbate 80 | DIG Info | Prostaglandin G/H synthase 1 (IC50 = 1 uM) | [2] | |||
Silicon dioxide | DIG Info | Albendazole monooxygenase (Protein expression downregulation) | [7] | |||
Drug Formulation 11 | DFM Info click to show the detail info of this DFM | |||||
All DIGs | Click to Show/Hide the Full List of DIGs in This DFM
Anhydrous lactose; Sodium stearyl fumarate; Propyl gallate; Ferric oxide red; Ferric oxide yellow; Titanium dioxide; Aluminum silicate; Povidone; Alcohol; Cellulose, microcrystalline; Hypromelloses; Polyethylene glycols
|
|||||
Dosage Form | 24 HR Extended Release Oral Tablet | |||||
Company | AstraZeneca | |||||
DIG(s) with Biological Activity | ||||||
DIG Name | DIG Info | Representative Biological Activity of This DIG | REF | |||
Propyl gallate | DIG Info | Arachidonate 5-lipoxygenase (Ki = 0.43 uM) | [2] | |||
Sodium stearyl fumarate | DIG Info | Leukemia K562 cells (IC50 = 20.2 ug.mL-1) | [4] | |||
Povidone | DIG Info | Cholesterol 25-hydroxylase (IC50 = 78.3 uM) | [9] | |||
Drug Formulation 12 | DFM Info click to show the detail info of this DFM | |||||
All DIGs | Click to Show/Hide the Full List of DIGs in This DFM
Lactose monohydrate; Sodium stearyl fumarate; Ferric oxide yellow; Magnesium aluminum silicate; Titanium dioxide; Polyethylene glycol 400; Polyoxyl 40 hydrogenated castor oil; Hydroxypropyl cellulose; Hypromellose 2208 (15000 mpa.s); Hypromellose 2910 (5 mpa.s)
|
|||||
Dosage Form | 24 HR Extended Release Oral Tablet | |||||
Company | Heritage Pharmaceuticals | |||||
DIG(s) with Biological Activity | ||||||
DIG Name | DIG Info | Representative Biological Activity of This DIG | REF | |||
Sodium stearyl fumarate | DIG Info | Leukemia K562 cells (IC50 = 20.2 ug.mL-1) | [4] | |||
Hydrogenated polyoxyl 40 castor oil | DIG Info | Cytochrome P450 2C9 (IC50 = 30 uM) | [5] | |||
Polyethylene glycol 400 | DIG Info | Albendazole monooxygenase (IC50 = 10.77 mg.mL-1) | [6] | |||
Drug Formulation 13 | DFM Info click to show the detail info of this DFM | |||||
All DIGs | Click to Show/Hide the Full List of DIGs in This DFM
Lactose; Sodium stearyl fumarate; Propyl gallate; Calcium silicate; Ferric oxide red; Titanium dioxide; Triacetin; Cellulose, microcrystalline; Hydroxypropyl cellulose (type h); Hypromelloses; Peg-40 castor oil
|
|||||
Dosage Form | 24 HR Extended Release Oral Tablet | |||||
Company | Qualitest Pharmaceuticals | |||||
DIG(s) with Biological Activity | ||||||
DIG Name | DIG Info | Representative Biological Activity of This DIG | REF | |||
Propyl gallate | DIG Info | Arachidonate 5-lipoxygenase (Ki = 0.43 uM) | [2] | |||
Sodium stearyl fumarate | DIG Info | Leukemia K562 cells (IC50 = 20.2 ug.mL-1) | [4] | |||
Drug Formulation 14 | DFM Info click to show the detail info of this DFM | |||||
All DIGs | Click to Show/Hide the Full List of DIGs in This DFM
Lactose monohydrate; Sodium stearyl fumarate; Propyl gallate; Calcium silicate; Ferric oxide red; Titanium dioxide; Triacetin; Cellulose, microcrystalline; Hydroxypropyl cellulose (type h); Hypromelloses; Peg-40 castor oil
|
|||||
Dosage Form | 24 HR Extended Release Oral Tablet | |||||
Company | American Health Packaging | |||||
DIG(s) with Biological Activity | ||||||
DIG Name | DIG Info | Representative Biological Activity of This DIG | REF | |||
Propyl gallate | DIG Info | Arachidonate 5-lipoxygenase (Ki = 0.43 uM) | [2] | |||
Sodium stearyl fumarate | DIG Info | Leukemia K562 cells (IC50 = 20.2 ug.mL-1) | [4] | |||
Drug Formulation 15 | DFM Info click to show the detail info of this DFM | |||||
All DIGs | Click to Show/Hide the Full List of DIGs in This DFM
Lactose monohydrate; Sodium stearyl fumarate; Ferric oxide red; Ferric oxide yellow; Kaolin; Titanium dioxide; Polyoxyl 40 hydrogenated castor oil; Cellulose, microcrystalline; Hydroxypropyl cellulose (type h); Hypromelloses; Polyethylene glycols
|
|||||
Dosage Form | 24 HR Extended Release Oral Tablet | |||||
Company | Carilion Materials Management; Glenmark Pharmaceutials | |||||
DIG(s) with Biological Activity | ||||||
DIG Name | DIG Info | Representative Biological Activity of This DIG | REF | |||
Sodium stearyl fumarate | DIG Info | Leukemia K562 cells (IC50 = 20.2 ug.mL-1) | [4] | |||
Hydrogenated polyoxyl 40 castor oil | DIG Info | Cytochrome P450 2C9 (IC50 = 30 uM) | [5] | |||
Drug Formulation 16 | DFM Info click to show the detail info of this DFM | |||||
All DIGs | Click to Show/Hide the Full List of DIGs in This DFM
Lactose; Sodium stearyl fumarate; Titanium dioxide; Polyethylene glycol
|
|||||
Dosage Form | 24 HR Extended Release Oral Tablet | |||||
Company | Ranbaxy Pharmaceuticals | |||||
DIG(s) with Biological Activity | ||||||
DIG Name | DIG Info | Representative Biological Activity of This DIG | REF | |||
Sodium stearyl fumarate | DIG Info | Leukemia K562 cells (IC50 = 20.2 ug.mL-1) | [4] | |||
Felodipine 2.5 mg tablet | Click to Show/Hide the Full List of Formulation(s): 14 Formulation(s) | |||||
Drug Formulation 1 | DFM Info click to show the detail info of this DFM | |||||
All DIGs | Click to Show/Hide the Full List of DIGs in This DFM
Anhydrous lactose; Sodium stearyl fumarate; Fd&c blue no. 2; Propyl gallate; Ferric oxide yellow; Magnesium oxide; Propylene glycol; Talc; Titanium dioxide; Polyoxyl 40 hydrogenated castor oil; Silicon dioxide; Cellulose, microcrystalline; Hydroxypropyl cellulose; Hypromelloses
|
|||||
Dosage Form | 24 HR Extended Release Oral Tablet | |||||
Company | Bryant Ranch Prepack | |||||
DIG(s) with Biological Activity | ||||||
DIG Name | DIG Info | Representative Biological Activity of This DIG | REF | |||
FD&C blue no. 2 | DIG Info | Adenosine receptor A3 (IC50 = 1 uM) | [2] | |||
Propyl gallate | DIG Info | Arachidonate 5-lipoxygenase (Ki = 0.43 uM) | [2] | |||
Sodium stearyl fumarate | DIG Info | Leukemia K562 cells (IC50 = 20.2 ug.mL-1) | [4] | |||
Propylene glycol | DIG Info | Albendazole monooxygenase (Inhibition ratio < 20 %) | [6] | |||
Hydrogenated polyoxyl 40 castor oil | DIG Info | Cytochrome P450 2C9 (IC50 = 30 uM) | [5] | |||
Silicon dioxide | DIG Info | Albendazole monooxygenase (Protein expression downregulation) | [7] | |||
Drug Formulation 2 | DFM Info click to show the detail info of this DFM | |||||
All DIGs | Click to Show/Hide the Full List of DIGs in This DFM
Lactose monohydrate; Sodium stearyl fumarate; Fd&c blue no. 2; Propyl gallate; Ferric oxide yellow; Titanium dioxide; Aluminum silicate; Polyethylene glycol 6000; Polyoxyl 40 hydrogenated castor oil; Silicon dioxide; Cellulose, microcrystalline; Hydroxypropyl cellulose; Hypromellose 2208 (100 mpa.s); Hypromellose 2910 (50 mpa.s); Hypromellose 2910 (6 mpa.s)
|
|||||
Dosage Form | 24 HR Extended Release Oral Tablet | |||||
Company | Aurobindo Pharma; Citron Pharma | |||||
DIG(s) with Biological Activity | ||||||
DIG Name | DIG Info | Representative Biological Activity of This DIG | REF | |||
FD&C blue no. 2 | DIG Info | Adenosine receptor A3 (IC50 = 1 uM) | [2] | |||
Propyl gallate | DIG Info | Arachidonate 5-lipoxygenase (Ki = 0.43 uM) | [2] | |||
Sodium stearyl fumarate | DIG Info | Leukemia K562 cells (IC50 = 20.2 ug.mL-1) | [4] | |||
Hydrogenated polyoxyl 40 castor oil | DIG Info | Cytochrome P450 2C9 (IC50 = 30 uM) | [5] | |||
Polyethylene glycol 6000 | DIG Info | Albendazole monooxygenase (Inhibition ratio < 70 %) | [6] | |||
Silicon dioxide | DIG Info | Albendazole monooxygenase (Protein expression downregulation) | [7] | |||
Drug Formulation 3 | DFM Info click to show the detail info of this DFM | |||||
All DIGs | Click to Show/Hide the Full List of DIGs in This DFM
D&c yellow no. 10; Fd&c red no. 40; Fd&c blue no. 1; Titanium dioxide; Hypromellose; Povidone; Silicon dioxide; Aluminum oxide; Carnauba wax; Cellulose, microcrystalline; Hydroxypropyl cellulose; Polyethylene glycol; Starch, corn
|
|||||
Dosage Form | 24 HR Extended Release Oral Tablet | |||||
Company | Physicians Total Care | |||||
DIG(s) with Biological Activity | ||||||
DIG Name | DIG Info | Representative Biological Activity of This DIG | REF | |||
Allura red AC dye | DIG Info | Solute carrier SLCO2B1 (Ki = 4.7 uM) | [2] | |||
FD&C blue no. 1 | DIG Info | Solute carrier SLCO2B1 (Ki = 13 uM) | [3] | |||
Quinoline yellow WS | DIG Info | Estrogen receptor alpha (IC50 = 18 uM) | [2] | |||
Allura red AC dye | DIG Info | Solute carrier SLCO2B1 (Ki = 2.59 uM) | [3] | |||
Hypromellose | DIG Info | Cytochrome P450 3A5 (IC50 = 19.4 uM) | [9] | |||
Povidone | DIG Info | Cholesterol 25-hydroxylase (IC50 = 78.3 uM) | [9] | |||
Silicon dioxide | DIG Info | Albendazole monooxygenase (Protein expression downregulation) | [7] | |||
Drug Formulation 4 | DFM Info click to show the detail info of this DFM | |||||
All DIGs | Click to Show/Hide the Full List of DIGs in This DFM
Lactose; Sodium stearyl fumarate; Fd&c blue no. 2; Propyl gallate; Ferric oxide yellow; Magnesium oxide; Propylene glycol; Talc; Titanium dioxide; Polyoxyl 40 hydrogenated castor oil; Cellulose, microcrystalline; Colloidal silicon dioxide; Hydroxypropyl cellulose; Hypromelloses
|
|||||
Dosage Form | 24 HR Extended Release Oral Tablet | |||||
Company | Torrent Pharmaceuticals | |||||
DIG(s) with Biological Activity | ||||||
DIG Name | DIG Info | Representative Biological Activity of This DIG | REF | |||
FD&C blue no. 2 | DIG Info | Adenosine receptor A3 (IC50 = 1 uM) | [2] | |||
Propyl gallate | DIG Info | Arachidonate 5-lipoxygenase (Ki = 0.43 uM) | [2] | |||
Sodium stearyl fumarate | DIG Info | Leukemia K562 cells (IC50 = 20.2 ug.mL-1) | [4] | |||
Propylene glycol | DIG Info | Albendazole monooxygenase (Inhibition ratio < 20 %) | [6] | |||
Hydrogenated polyoxyl 40 castor oil | DIG Info | Cytochrome P450 2C9 (IC50 = 30 uM) | [5] | |||
Drug Formulation 5 | DFM Info click to show the detail info of this DFM | |||||
All DIGs | Click to Show/Hide the Full List of DIGs in This DFM
Anhydrous lactose; Sodium stearyl fumarate; Propyl gallate; Titanium dioxide; Sodium aluminium silicate; Polyethylene glycol 400; Polyoxyl 40 hydrogenated castor oil; Silicon dioxide; Cellulose, microcrystalline; Hydroxypropyl cellulose (type h); Hypromellose 2910 (15000 mpa.s); Hypromelloses
|
|||||
Dosage Form | 24 HR Extended Release Oral Tablet | |||||
Company | Jubilant Cadista Pharmaceuticals | |||||
DIG(s) with Biological Activity | ||||||
DIG Name | DIG Info | Representative Biological Activity of This DIG | REF | |||
Propyl gallate | DIG Info | Arachidonate 5-lipoxygenase (Ki = 0.43 uM) | [2] | |||
Sodium stearyl fumarate | DIG Info | Leukemia K562 cells (IC50 = 20.2 ug.mL-1) | [4] | |||
Hydrogenated polyoxyl 40 castor oil | DIG Info | Cytochrome P450 2C9 (IC50 = 30 uM) | [5] | |||
Polyethylene glycol 400 | DIG Info | Albendazole monooxygenase (IC50 = 10.77 mg.mL-1) | [6] | |||
Silicon dioxide | DIG Info | Albendazole monooxygenase (Protein expression downregulation) | [7] | |||
Drug Formulation 6 | DFM Info click to show the detail info of this DFM | |||||
All DIGs | Click to Show/Hide the Full List of DIGs in This DFM
Lactose monohydrate; D&c yellow no. 10; Sodium stearyl fumarate; Fd&c blue no. 2; Ferric oxide yellow; Kaolin; Titanium dioxide; Polyoxyl 40 hydrogenated castor oil; Cellulose, microcrystalline; Hydroxypropyl cellulose (type h); Hypromelloses; Polyethylene glycols
|
|||||
Dosage Form | 24 HR Extended Release Oral Tablet | |||||
Company | Glenmark Pharmaceutials | |||||
DIG(s) with Biological Activity | ||||||
DIG Name | DIG Info | Representative Biological Activity of This DIG | REF | |||
FD&C blue no. 2 | DIG Info | Adenosine receptor A3 (IC50 = 1 uM) | [2] | |||
Quinoline yellow WS | DIG Info | Estrogen receptor alpha (IC50 = 18 uM) | [2] | |||
Sodium stearyl fumarate | DIG Info | Leukemia K562 cells (IC50 = 20.2 ug.mL-1) | [4] | |||
Hydrogenated polyoxyl 40 castor oil | DIG Info | Cytochrome P450 2C9 (IC50 = 30 uM) | [5] | |||
Drug Formulation 7 | DFM Info click to show the detail info of this DFM | |||||
All DIGs | Click to Show/Hide the Full List of DIGs in This DFM
Lactose monohydrate; D&c yellow no. 10; Sodium stearyl fumarate; Ferric oxide yellow; Magnesium aluminum silicate; Titanium dioxide; Polyethylene glycol 400; Polyoxyl 40 hydrogenated castor oil; Hydroxypropyl cellulose; Hypromellose 2208 (15000 mpa.s); Hypromellose 2910 (5 mpa.s)
|
|||||
Dosage Form | 24 HR Extended Release Oral Tablet | |||||
Company | Heritage Pharmaceuticals | |||||
DIG(s) with Biological Activity | ||||||
DIG Name | DIG Info | Representative Biological Activity of This DIG | REF | |||
Quinoline yellow WS | DIG Info | Estrogen receptor alpha (IC50 = 18 uM) | [2] | |||
Sodium stearyl fumarate | DIG Info | Leukemia K562 cells (IC50 = 20.2 ug.mL-1) | [4] | |||
Hydrogenated polyoxyl 40 castor oil | DIG Info | Cytochrome P450 2C9 (IC50 = 30 uM) | [5] | |||
Polyethylene glycol 400 | DIG Info | Albendazole monooxygenase (IC50 = 10.77 mg.mL-1) | [6] | |||
Drug Formulation 8 | DFM Info click to show the detail info of this DFM | |||||
All DIGs | Click to Show/Hide the Full List of DIGs in This DFM
D&c yellow no. 10; Fd&c red no. 40; Fd&c blue no. 1; Titanium dioxide; Silicon dioxide; Aluminum oxide; Carnauba wax; Cellulose, microcrystalline; Hydroxypropyl cellulose (type h); Hypromelloses; Polyethylene glycols; Povidones
|
|||||
Dosage Form | 24 HR Extended Release Oral Tablet | |||||
Company | AvKARE; Carilion Materials Management; Sun Pharmaceutical Industries | |||||
DIG(s) with Biological Activity | ||||||
DIG Name | DIG Info | Representative Biological Activity of This DIG | REF | |||
Allura red AC dye | DIG Info | Solute carrier SLCO2B1 (Ki = 4.7 uM) | [2] | |||
FD&C blue no. 1 | DIG Info | Solute carrier SLCO2B1 (Ki = 13 uM) | [3] | |||
Quinoline yellow WS | DIG Info | Estrogen receptor alpha (IC50 = 18 uM) | [2] | |||
Allura red AC dye | DIG Info | Solute carrier SLCO2B1 (Ki = 2.59 uM) | [3] | |||
Silicon dioxide | DIG Info | Albendazole monooxygenase (Protein expression downregulation) | [7] | |||
Drug Formulation 9 | DFM Info click to show the detail info of this DFM | |||||
All DIGs | Click to Show/Hide the Full List of DIGs in This DFM
D&c yellow no. 10; Fd&c red no. 40; Fd&c blue no. 1; Titanium dioxide; Silicon dioxide; Aluminum oxide; Carnauba wax; Cellulose, microcrystalline; Hydroxypropyl cellulose; Hypromelloses; Polyethylene glycols; Povidone k29/32
|
|||||
Dosage Form | 24 HR Extended Release Oral Tablet | |||||
Company | Richmond Pharmaceuticals | |||||
DIG(s) with Biological Activity | ||||||
DIG Name | DIG Info | Representative Biological Activity of This DIG | REF | |||
Allura red AC dye | DIG Info | Solute carrier SLCO2B1 (Ki = 4.7 uM) | [2] | |||
FD&C blue no. 1 | DIG Info | Solute carrier SLCO2B1 (Ki = 13 uM) | [3] | |||
Quinoline yellow WS | DIG Info | Estrogen receptor alpha (IC50 = 18 uM) | [2] | |||
Allura red AC dye | DIG Info | Solute carrier SLCO2B1 (Ki = 2.59 uM) | [3] | |||
Silicon dioxide | DIG Info | Albendazole monooxygenase (Protein expression downregulation) | [7] | |||
Drug Formulation 10 | DFM Info click to show the detail info of this DFM | |||||
All DIGs | Click to Show/Hide the Full List of DIGs in This DFM
Butylated hydroxytoluene; Sodium stearyl fumarate; Butylated hydroxyanisole; Titanium dioxide; Silicon dioxide; Cellulose, microcrystalline; Hypromelloses; Polydextrose; Polyethylene glycols; Povidones
|
|||||
Dosage Form | 24 HR Extended Release Oral Tablet | |||||
Company | Mylan Pharamceuticals | |||||
DIG(s) with Biological Activity | ||||||
DIG Name | DIG Info | Representative Biological Activity of This DIG | REF | |||
Butylated hydroxytoluene | DIG Info | Carbonic anhydrase II (Ki = 630 nM) | [8] | |||
Sodium stearyl fumarate | DIG Info | Leukemia K562 cells (IC50 = 20.2 ug.mL-1) | [4] | |||
Butylhydroxyanisole | DIG Info | Prostaglandin G/H synthase 2 (IC50 = 2.6 uM) | [2] | |||
Silicon dioxide | DIG Info | Albendazole monooxygenase (Protein expression downregulation) | [7] | |||
Drug Formulation 11 | DFM Info click to show the detail info of this DFM | |||||
All DIGs | Click to Show/Hide the Full List of DIGs in This DFM
Lactose; Sodium stearyl fumarate; Fd&c blue no. 2; Propyl gallate; Calcium silicate; Ferric oxide yellow; Titanium dioxide; Triacetin; Cellulose, microcrystalline; Hydroxypropyl cellulose (type h); Hypromelloses; Peg-40 castor oil
|
|||||
Dosage Form | 24 HR Extended Release Oral Tablet | |||||
Company | Qualitest Pharmaceuticals | |||||
DIG(s) with Biological Activity | ||||||
DIG Name | DIG Info | Representative Biological Activity of This DIG | REF | |||
FD&C blue no. 2 | DIG Info | Adenosine receptor A3 (IC50 = 1 uM) | [2] | |||
Propyl gallate | DIG Info | Arachidonate 5-lipoxygenase (Ki = 0.43 uM) | [2] | |||
Sodium stearyl fumarate | DIG Info | Leukemia K562 cells (IC50 = 20.2 ug.mL-1) | [4] | |||
Drug Formulation 12 | DFM Info click to show the detail info of this DFM | |||||
All DIGs | Click to Show/Hide the Full List of DIGs in This DFM
Anhydrous lactose; Sodium stearyl fumarate; Propyl gallate; Ferric oxide red; Ferric oxide yellow; Titanium dioxide; Aluminum silicate; Povidone; Alcohol; Cellulose, microcrystalline; Hypromelloses; Polyethylene glycols
|
|||||
Dosage Form | 24 HR Extended Release Oral Tablet | |||||
Company | AstraZeneca | |||||
DIG(s) with Biological Activity | ||||||
DIG Name | DIG Info | Representative Biological Activity of This DIG | REF | |||
Propyl gallate | DIG Info | Arachidonate 5-lipoxygenase (Ki = 0.43 uM) | [2] | |||
Sodium stearyl fumarate | DIG Info | Leukemia K562 cells (IC50 = 20.2 ug.mL-1) | [4] | |||
Povidone | DIG Info | Cholesterol 25-hydroxylase (IC50 = 78.3 uM) | [9] | |||
Drug Formulation 13 | DFM Info click to show the detail info of this DFM | |||||
All DIGs | Click to Show/Hide the Full List of DIGs in This DFM
Lactose monohydrate; Sodium stearyl fumarate; Titanium dioxide; Polyoxyl 40 hydrogenated castor oil; Silicon dioxide; Cellulose, microcrystalline; Hydroxypropyl cellulose; Hypromelloses; Polyethylene glycol
|
|||||
Dosage Form | 24 HR Extended Release Oral Tablet | |||||
Company | Wockhardt | |||||
DIG(s) with Biological Activity | ||||||
DIG Name | DIG Info | Representative Biological Activity of This DIG | REF | |||
Sodium stearyl fumarate | DIG Info | Leukemia K562 cells (IC50 = 20.2 ug.mL-1) | [4] | |||
Hydrogenated polyoxyl 40 castor oil | DIG Info | Cytochrome P450 2C9 (IC50 = 30 uM) | [5] | |||
Silicon dioxide | DIG Info | Albendazole monooxygenase (Protein expression downregulation) | [7] | |||
Drug Formulation 14 | DFM Info click to show the detail info of this DFM | |||||
All DIGs | Click to Show/Hide the Full List of DIGs in This DFM
Lactose; Sodium stearyl fumarate; Fd&c blue no. 2; Ferric oxide yellow; Titanium dioxide; Hydroxypropyl cellulose
|
|||||
Dosage Form | 24 HR Extended Release Oral Tablet | |||||
Company | Ranbaxy Pharmaceuticals | |||||
DIG(s) with Biological Activity | ||||||
DIG Name | DIG Info | Representative Biological Activity of This DIG | REF | |||
FD&C blue no. 2 | DIG Info | Adenosine receptor A3 (IC50 = 1 uM) | [2] | |||
Sodium stearyl fumarate | DIG Info | Leukemia K562 cells (IC50 = 20.2 ug.mL-1) | [4] | |||
If you find any error in data or bug in web service, please kindly report it to Dr. Zhang and Dr. Mou.